Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 68 cancer drugs PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


cancer drugs PhD Projects, Programmes & Scholarships

We have 68 cancer drugs PhD Projects, Programmes & Scholarships

(MRC DTP CASE) Multiomic evaluation of differential drug response in metastatic breast cancers

Breast cancers are the most common cancers in women. Estrogen Receptor (ER) plays a major role in breast cancer growth. To stop the cancer from growing further, clinically successful ER-targeting therapies like Fulvestrant, etc were developed. Read more
Last chance to apply

‘Payload-Releasing Electrophiles’ – a new disease-selective delivery strategy for diagnostics and therapeutics

Graduate Teaching Assistantship. This is a Graduate Training Assistantship (GTA), which means that you will be required to do some teaching, particularly lab demonstrating, as part of your training. Read more

New Anticancer Therapeutics Based on Luminescent Transition Metal Complexes

Cancer is one of the leading causes of death around the world. Over 50% of cancer tumours are treated with platinum-based metal complexes, like cisplatin and its derivatives. Read more

Study at Griffith University’s Institute for Glycomics and help fight diseases of global impact

Did you know that more than 17 million people die from infectious diseases and over 9 million people die from cancer every year across the world?. Read more

Identifying secreted biomarkers in brain cancer

Stage IV brain cancer or glioblastoma (GBM) poses a major challenge with only 5 FDA approved chemotherapeutic drugs available for treatment. Read more

New Drugs for Brain Tumours: Prodrugs of Diazopropyne

  Research Group: Medicines Development and Pharmaceutical Sciences
The propargyl group, introduced to temozolomide-like drugs for brain tumours by our colleagues in Nottingham, shows considerable pre-clinical promise and… Read more

Structural-guided PROTAC targeting of BMX to modulate apoptotic sensitivity in disease

What determines at the molecular level whether a cell lives or dies? Regulation of the cellular life–death switch is essential in healthy cells for normal foetal development and for the clearance of damaged cells. Read more

Filtering Results